Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE), 2025
Perspectives on GHD Treatment Long-Term Data and Transition Management
Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE), 2025
ESPE-ESE 2025
10 - 13 May 2025
Perspectives on GHD Treatment Long-Term Data and Transition Management
Share
Copy link
{{pageUrl}}
Keywords
Rare Endocrine Disorder
Congress industry session
Somapacitan
PHASE 3 (RCT)